FDA approves synthetic blood thinner.
D000075202:Contraindications; D017277:Drug Approval; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D000077425:Fondaparinux; D006622:Hip Prosthesis; D006801:Humans; D007720:Knee Prosthesis; D011134:Polysaccharides / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D005343:Fibrinolytic Agents; D011134:Polysaccharides; D000077425:Fondaparinux